Darifenacin hydrobromide (CAS No. 133099-07-7) is supplied by Jinan Shenghe Chemical Co., Ltd. with a typical purity of 按批次COA提供(不公开发布). Main applications include Pharmaceutical Intermediates & APIs. Bulk quantities are available with COA; purity and packaging are subject to batch COA and order confirmation.
| CAS Number | 133099-07-7 |
|---|---|
| Molecular Formula | C28H31BrN2O2 |
| Molecular Weight | 507.5 |
| Purity | 按批次COA提供(不公开发布) |
| Packaging | 按订单/批次确认(不公开发布) |
| Applications | Pharmaceutical Intermediates & APIs |
| Category | Pharmaceutical Intermediates & APIs |
Pharmaceutical Intermediates & APIs
COA (Certificate of Analysis) is provided with every batch. MSDS/technical data sheets and third-party test reports are available on request. Purity and packaging are subject to batch COA and order confirmation.
The CAS number of Darifenacin hydrobromide is 133099-07-7.
Typical purity is 按批次COA提供(不公开发布), supplied in 按订单/批次确认(不公开发布), with COA provided.
Main applications include Pharmaceutical Intermediates & APIs.
Email info@591daili.com or reach us on WhatsApp with the product name, CAS number and required quantity; quotes within one business day. Supplier: Jinan Shenghe Chemical Co., Ltd..
Darifenacin hydrobromide · CAS 133099-07-7 · C28H31BrN2O2. UNII CR02EYQ8GV.
| CAS Registry Number | 133099-07-7 |
|---|---|
| PubChem CID | 444030 |
| Molecular formula | C28H31BrN2O2 |
| IUPAC name | 2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide;hydrobromide |
| UNII (FDA) | CR02EYQ8GV |
| Molecular Weight | 507.5 |
|---|---|
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 7 |
| Exact Mass | 506.15689 |
| Monoisotopic Mass | 506.15689 |
| Topological Polar Surface Area | 55.6 |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 607 |
| Reported hazard statements | H315 (95.1%), H319 (100%), H335 (95.1%) |
|---|
H315 (95.1%): Causes skin irritation [Warning Skin corrosion/irritation]
H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
Darifenacin hydrobromide; darifenacin HBr; 133099-07-7; UK 88525-04 hydrobromide; DTXSID9046780; CR02EYQ8GV; UK-88525-04 (HYDROBROMIDE); Uk-88525-04 (hbr); DTXCID7026780; CHEBI:31455; (S)-2-{1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)-3-pyrrolidnyl}-2,2-diphenylacetamide hydrobromide; (S)-2-(1-(2-(2,3-DIHYDROBENZOFURAN-5-YL)ETHYL)-3-PYRROLIDNYL)-2,2-DIPHENYLACETAMIDE HYDROBROMIDE; (S)-2-{1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidnyl}-2,2-diphenylacetamide hydrobromide; Darifenacin 15 mg; Darifenacin 7.5 mg; RefChem:57151
CAS 133099-07-7; molecular formula C28H31BrN2O2; molecular weight — g/mol.
Darifenacin hydrobromide, darifenacin HBr, 133099-07-7, UK 88525-04 hydrobromide, DTXSID9046780, CR02EYQ8GV.
Hazard statements reported: H315, H319, H335.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.
Supplier: Jinan Shenghe Chemical Co., Ltd.
中文页面: 氢溴酸达非那新